Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 2
1963 1
1964 1
1965 2
1971 1
1973 1
1978 1
1979 2
1980 1
1981 3
1982 3
1983 1
1985 2
1987 1
1988 3
1989 4
1990 6
1991 10
1992 6
1993 5
1994 8
1995 7
1996 11
1997 6
1998 11
1999 11
2000 9
2001 11
2002 18
2003 16
2004 24
2005 36
2006 32
2007 35
2008 46
2009 49
2010 55
2011 64
2012 88
2013 87
2014 50
2015 93
2016 93
2017 89
2018 111
2019 103
2020 138
2021 173
2022 155
2023 104
2024 128
2025 135
2026 22

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,828 results

Results by year

Filters applied: . Clear all
Page 1
Reply.
Chiang MF, Quinn GE, Fielder AR, Chan RVP, Fleck B; of the International Committee for the Classification of Retinopathy of Prematurity. Chiang MF, et al. Ophthalmology. 2022 Mar;129(3):e36-e37. doi: 10.1016/j.ophtha.2021.10.020. Epub 2021 Nov 26. Ophthalmology. 2022. PMID: 34844763 No abstract available.
Reply.
Quinn GE, Fielder AR, Chan RVP, Chiang MF; International Committee for the Classification of Retinopathy of Prematurity. Quinn GE, et al. Among authors: chiang mf. Ophthalmology. 2022 Jun;129(6):e65-e66. doi: 10.1016/j.ophtha.2022.01.026. Epub 2022 Mar 4. Ophthalmology. 2022. PMID: 35256216 No abstract available.
Efficacy and Safety of RelabotulinumtoxinA, a New Ready-to-Use Liquid Formulation Botulinum Toxin: Results From the READY-1 Double-Blind, Randomized, Placebo-Controlled Phase 3 Trial in Glabellar Lines.
Shridharani SM, Moradi A, Donofrio L, Gold MH, Biesman B, Chiang M, George R, Polder K, Solish N, Schwarcz, Lin X, Axén E, Prygova I. Shridharani SM, et al. Among authors: chiang m. Aesthet Surg J. 2024 Nov 15;44(12):1330-1340. doi: 10.1093/asj/sjae131. Aesthet Surg J. 2024. PMID: 38913088 Free PMC article. Clinical Trial.
Firing up chromatin to forge T-ALL.
Chiang MY. Chiang MY. Blood. 2022 Apr 21;139(16):2418-2420. doi: 10.1182/blood.2021015364. Blood. 2022. PMID: 35446377 Free PMC article. No abstract available.
1,828 results